Ikarian Capital, LLC Adicet Bio, Inc. Transaction History

Ikarian Capital, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$10.26 - $20.81 $3.74 Million - $7.58 Million	-364,134 Reduced 71.77%	143,214 $2.09 Million
Q1 2022 May 13, 2022	BUY	$11.53 - $19.97 $345,092 - $597,702	29,930 Added 6.27%	507,348 $10.1 Million
Q4 2021 Feb 14, 2022	BUY	$7.37 - $17.49 $626,450 - $1.49 Million	85,000 Added 21.66%	477,418 $8.35 Million
Q3 2021 Nov 15, 2021	BUY	$6.29 - $9.93 $1.68 Million - $2.65 Million	266,874 Added 212.57%	392,418 $3.08 Million
Q2 2021 Aug 16, 2021	SELL	$9.19 - $15.93 $87,764 - $152,131	-9,550 Reduced 7.07%	125,544 $1.29 Million
Q1 2021 May 17, 2021	SELL	$12.12 - $17.17 $474,897 - $672,772	-39,183 Reduced 22.48%	135,094 $1.77 Million
Q4 2020 Feb 12, 2021	SELL	$10.36 - $14.77 $1.04 Million - $1.48 Million	-100,000 Reduced 36.46%	174,277 $2.45 Million
Q3 2020 Nov 16, 2020	BUY	$10.18 - $21.4 $2.79 Million - $5.87 Million	274,277 New	274,277 $3.26 Million

59.2M

4.2K

6.7K

Ticker ACET
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,030,800
Market Cap $39.6M
Description
Adicet Bio, Inc., a biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for cancer and other diseases. The company offers gamma delta T cells engineered with chimeric antigen receptors and T cell receptor-like antibodies to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune respo...

Get notified when there are updates to the investment portfolio of Ikarian Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Ikarian Capital, LLC with notifications on news.